Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England

Diabetes Care

Volumn 35, Issue 3, 2012, Pages 592-596

  Jones, Colin D ^a   Greenwood, Richard H ^a   Misra, Aseema ^a   Bachmann, Max O ^b  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIETARY INTAKE; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PROGNOSIS; RETINA EXAMINATION; RETINA MACULOPATHY; RISK FACTOR; SCREENING; UNITED KINGDOM;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; ENGLAND; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED;

EID: 84859073127     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0943     Document Type: Article

References (14)

1. Scanlon PH. The English national screening programme for sight-threatening diabetic retinopathy. J Med Screen 2008;15:1-4 (Pubitemid 351629537)
2. American Diabetes Association. Diabetic retinopathy. Diabetes Care 1998;21:157-159
3. Royal College of Ophthalmologists. Guidelines for Diabetic Retinopathy. London, Royal College of Ophthalmologists, 1997, p. 1-104
4. Bachmann MO, Nelson SJ. Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model. J Epidemiol Community Health 1998;52:45-52 (Pubitemid 28052603)
5. Misra A, Bachmann MO, Greenwood RH, et al. Trends inyield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabet Med 2009;26:1040-1047
6. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 1989;107:244-249 (Pubitemid 19055345)
7. Retinopathy Working Party. A protocol for screening for diabetic retinopathy in Europe. Diabet Med 1991;8:263-267
8. Harding S, Greenwood R, Aldington S, et al.; Diabetic Retinopathy Grading and Disease Management Working Party. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 2003;20:965-971 (Pubitemid 41701477)
9. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic colour fundus photographsdan extension of the modified Airlie House classification. ETRS report number 10. Ophthalmol 1991;98:786-806
10. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-532 (Pubitemid 14127839)
11. Younis N, Broadbent DM, Vora JP, Harding SP; Liverpool Diabetic Eye Study. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003;361:195-200
12. Kohner EM, Stratton IM, Aldington SJ, et al. Relationship between the severity of retinopathy and progression to photocoagulation in patients with type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet Med 2001;18:156-163
13. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001;44:156-163 (Pubitemid 32156199)
14. Manaviat MR, Rashidi M, Afkhami-Ardekani M. Four years incidence of diabetic retinopathy and effective factors on its progression in type II diabetes. Eur J Ophthalmol 2008;18:572-577